Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(16/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(16/week)
News
United States
(600/week)
Manufacturing
(427/week)
Energy
(314/week)
Technology
(448/week)
Other Manufacturing
(344/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
American Association for the Study of Liver Diseases
Nov 05, 2020
Lipocine to Present Preclinical Data on Therapeutic Potential of LPCN 1144 in Hepatic Fibrosis and NASH at The Liver Meeting Digital Experience(TM)
Nov 09, 2019
qFIBS Demonstrates Suitability for Nonalcoholic Steatohepatitis (NASH) Assessment in Clinical Trials and Patient Care with Full Quantification of All Crucial Histopathological Features
Oct 31, 2019
Sirnaomics to Present Preclinical STP705 Data Suggesting Reduction in Liver Fibrosis at AASLD Liver Meeting
Oct 31, 2019
Galmed Pharmaceuticals to Present New Data on Aramchol Effect on Glucose Metabolism, MoA and Clinical Results at AASLD 2019
Oct 01, 2019
Lipocine To Present LPCN 1144 Poster Of Distinction At The Liver Meeting® 2019
Aug 08, 2019
Laboratory for Advanced Medicine Strengthens Hepatology Board with Addition of Three Distinguished Medical Doctors
Jul 02, 2019
HighTide Therapeutics Expands Leadership Team with Appointment of Adrian M. Di Bisceglie, M.D., as Chief Medical Officer
May 03, 2019
DURECT Corporation to Present Preliminary Data from the Ongoing DUR-928 Alcoholic Hepatitis Phase 2a Trial and Report First Quarter 2019 Financial Results
Mar 13, 2019
Viking Therapeutics Reports Fourth Quarter and Year-End 2018 Financial Results and Provides Corporate Update
Nov 09, 2018
Symic Bio Selected for "The Best of The Liver Meeting 2018" at AASLD
Nov 06, 2018
Cirius Therapeutics Announces Two Posters on MSDC-0602K to be Presented at The Liver Meeting 2018
Nov 05, 2018
Ascletis to Present Phase II / III Clinical Study for Its All-oral HCV Treatment at the 69th Annual meeting of AASLD
Oct 02, 2018
Galmed Pharmaceuticals Announces a Late-Breaking Abstract on Aramchol(TM) to be Presented at the American Association for the Study of Liver Diseases (AASLD) - The Liver Meeting®
Oct 23, 2017
Data on the Clinical Activity of Simeprevir in Combination With AL-335 and Odalasvir (JNJ-4178) Presented at the 2017 Liver Meeting(TM)
Oct 20, 2017
Cirius Therapeutics to Present Poster at The Liver Meeting 2017
Oct 19, 2017
Sequana Medical Announces 2017 AASLD Poster Presentation
Oct 10, 2017
Metacrine's FXR Program to be Highlighted in Three Abstracts at The Liver Meeting® 2017 in Washington, D.C.
Oct 05, 2017
Galmed Pharmaceuticals Announces Publication of Data on Aramchol(TM) Mechanism of Action in Hepatology Communications. Data Will Also Be Presented at AASLD
Aug 16, 2017
Renowned Liver Disease Specialist Named Director of Hepatology at NYU Langone Health
Jun 05, 2017
Can-Fite Establishes Clinical Advisory Board for NAFLD/NASH
Latest News
Apr 26, 2024
Peugeot Sport Aims for the Endurance Racing Finish Line With Simulation From Dassault Systèmes
Apr 26, 2024
Orbia Announces First Quarter 2024 Financial Results
Apr 26, 2024
Metro Storage LLC Invests in Sustainable Future with Rooftop Solar Energy Panels
Apr 26, 2024
Freeport-McMoRan Publishes 2023 Annual Report on Sustainability
Apr 26, 2024
SJW Group Announces First Quarter 2024 Financial Results
Apr 26, 2024
Resolutions Adopted at the Annual General Ordinary and Extraordinary Shareholders’ Meeting for Grupo...
Apr 26, 2024
Delek Logistics Partners, LP Increases Quarterly Cash Distribution to $1.07 per Common Limited Partner Unit
Apr 26, 2024
NOV Reports First Quarter 2024 Results, Return of Capital Framework, $1 Billion Share Repurchase...
View all News
Agenda
24
September
Hilton London Syon Park, London, UK
Defence Transformation Conference
Returning for its 8th year, Defence Transformation 2024 will feature an updated format that will address all aspects of...
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
21
May
Paris Marriott Rive Gauche & Conference Center
Future Artillery, 21-23 May 2024, Paris Marriott Rive Gauche & Conference Center, France
DELIVERING FIRES IN THE MULTI-DOMAIN BATTLESPACE As artillery reasserts itself as the ‘King of Battlefield’ in the wake...
View All Events